Last Updated : October 28, 2010
Details
FilesGeneric Name:
Velaglucerase alfa
Project Status:
Complete
Therapeutic Area:
Gaucher Disease
Manufacturer:
Shire Human Genetic Therapies
Call for patient/clinician input open:
Brand Name:
VPRIV
Project Line:
Reimbursement Review
Project Number:
SR0215-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Gaucher Disease
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : October 28, 2010